Publications
- Relationship between risk factors for impaired bone health and HR-pQCT in young adults with type 1 diabetes
- Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
- ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes
- ISPAD Clinical Practice Consensus Guidelines 2022: Management and support of children and adolescents with diabetes in school
- ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes
- ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes
- ISPAD Clinical Practice Consensus Guidelines 2022: Editorial
- Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes
- ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents
- A centennial review of discoveries and advances in diabetes: Children and youth
